Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7604)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2015 (publication date) through Feb 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ramos-Esquivel A. Monitoring anticoagulant therapy with new oral agents. World J Methodol 2015; 5(4): 212-215 [PMID: 26713281 DOI: 10.5662/wjm.v5.i4.212] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v5/i4/212.htm |
| Number | Citing Articles |
| 1 |
Tess Van Meerhaeghe, Alexandre Cez, Karine Dahan, Emmanuel Esteve, Ismail Elalamy, Jean Jacques Boffa, Eleonore Ponlot. Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome. TH Open 2022; 6(04): e299 doi: 10.1055/a-1920-6224
|
| 2 |
Ekta Yogeshkumar Pandya, Elizabeth Anderson, Clara Chow, Yishen Wang, Beata Bajorek. Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting. Therapeutic Advances in Drug Safety 2018; 9(2): 97 doi: 10.1177/2042098617744926
|
| 3 |
Howard H. Z. Thom, Will Hollingworth, Reecha Sofat, Zhenru Wang, Wei Fang, Pritesh N. Bodalia, Peter A. Bryden, Philippa A. Davies, Deborah M. Caldwell, Sofia Dias, Diane Eaton, Julian P. T. Higgins, Aroon D. Hingorani, Jose A. Lopez-Lopez, George N. Okoli, Alison Richards, Chris Salisbury, Jelena Savović, Annya Stephens-Boal, Jonathan A. C. Sterne, Nicky J. Welton. Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis. MDM Policy & Practice 2019; 4(2) doi: 10.1177/2381468319866828
|
| 4 |
Mario González‐Sales, Lanyan Fang, Myong‐Jin Kim, Liang Zhao. Model‐Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee Replacement. The Journal of Clinical Pharmacology 2017; 57(12): 1591 doi: 10.1002/jcph.930
|
| 5 |
|
| 6 |
Alireza Ghodsi, Leila Etemad, Bita Dadpour, Babak Mostafazadeh, Mohammad Moshiri. Conservative management of massive rivaroxaban overdose: A case report and literature review. Clinical Case Reports 2021; 9(11) doi: 10.1002/ccr3.5023
|
| 7 |
Michael B. Simmers, Banumathi K. Cole, Martin L. Ogletree, Zhu Chen, Yiming Xu, Ling-jie Kong, Nigel Mackman, Brett R. Blackman, Brian R. Wamhoff. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thrombosis Research 2016; 143: 34 doi: 10.1016/j.thromres.2016.04.022
|
| 8 |
Sinan Cem Uzunget, Togay Evrin, Sezen Baglan Uzunget, Zamir Kemal Ertürk, Egemen Akıncıoğlu, Saffet Özdemir, Atila Korkmaz. Evaluation of activated charcoal and lipid emulsion treatment in model of acute rivaroxaban toxicity. The American Journal of Emergency Medicine 2018; 36(8): 1346 doi: 10.1016/j.ajem.2017.12.039
|
| 9 |
Jean Terrier, Youssef Daali, Pierre Fontana, Chantal Csajka, Jean-Luc Reny. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants. Clinical Pharmacokinetics 2019; 58(12): 1517 doi: 10.1007/s40262-019-00792-y
|
| 10 |
Tony Kim, Matthew Finkelman, Bhavik Desai, Arwa Farag. Direct‐acting oral anti‐coagulants in dental practice: A Retrospective Observational Study (Part 1). Oral Diseases 2021; 27(4): 1052 doi: 10.1111/odi.13604
|
| 11 |
Aastha Gupta, D. S. Udayakumar, Renu Saxena. Hematopathology. 2019; : 377 doi: 10.1007/978-981-13-7713-6_22
|